FTO and ovarian carcinoma: TCGA and GTEX database analyses showed that FTO mRNA expression was decreased in ovarian cancer patients (Figure 1c), and the CPTAC database showed that FTO protein levels were also decreased in ovarian cancer patients (Figure 1d).